CICLOPIROX

CICLOPIROX was reported 2572 times

CICLOPIROX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COLLOID BRAIN CYST 2 0.0444
1 MYELOMALACIA 4 0.0381
2 TRANSIENT APHASIA 4 0.0305
3 EAR LOBE INFECTION 3 0.0294
4 ACTINIC ELASTOSIS 2 0.0263
5 ANAPLASTIC ASTROCYTOMA 3 0.0182
6 DERMATOPHYTOSIS OF NAIL 2 0.0168
7 SUPERFICIAL VEIN THROMBOSIS 13 0.0154
8 NAIL HYPERTROPHY 3 0.0148
9 NAIL GROWTH ABNORMAL 15 0.0136
10 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 6 0.0134
11 TYPE IIA HYPERLIPIDAEMIA 3 0.0128
12 NAIL PIGMENTATION 3 0.0124
13 INTERCOSTAL NEURALGIA 2 0.0112
14 PANCREATOLITHIASIS 4 0.0100
15 MICROGRAPHIC SKIN SURGERY 2 0.0093
16 DECREASED VIBRATORY SENSE 3 0.0088
17 BASAL GANGLIA INFARCTION 3 0.0087
18 ONYCHOMYCOSIS 37 0.0084
19 NAIL DISCOLOURATION 33 0.0084
20 LENTIGO 4 0.0081
21 SPINAL CORD HAEMORRHAGE 3 0.0075
22 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 3 0.0070
23 ONYCHALGIA 7 0.0070
24 TREMOR NEONATAL 3 0.0067
25 IMPAIRED FASTING GLUCOSE 2 0.0066
26 ONYCHOLYSIS 10 0.0064
27 DYSCHROMATOPSIA 5 0.0060
28 ESSENTIAL HYPERTENSION 10 0.0055
29 ALTERNARIA INFECTION 2 0.0054
30 NAIL DYSTROPHY 3 0.0054
31 NAIL INJURY 3 0.0053
32 HYPERPARATHYROIDISM SECONDARY 13 0.0052
33 GENITAL ABSCESS 2 0.0050
34 CRANIOTOMY 2 0.0049
35 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
36 FRACTURE DISPLACEMENT 2 0.0047
37 HAEMANGIOMA OF SKIN 2 0.0046
38 FUNGAL FOOT INFECTION 2 0.0046
39 NEPHROGENIC ANAEMIA 20 0.0043
40 ACCIDENT AT HOME 2 0.0039
41 PNEUMONIA KLEBSIELLA 7 0.0038
42 SEBORRHOEIC DERMATITIS 6 0.0036
43 ADENOMA BENIGN 3 0.0035
44 COLON INJURY 2 0.0035
45 HAEMANGIOMA 8 0.0035
46 ENDOCRINE OPHTHALMOPATHY 3 0.0035
47 SEBORRHOEIC KERATOSIS 5 0.0034
48 TELANGIECTASIA 3 0.0031
49 CELLULITIS STAPHYLOCOCCAL 2 0.0031
50 CATARACT NUCLEAR 2 0.0030
51 PRODUCT RESIDUE PRESENT 16 0.0030
52 MARROW HYPERPLASIA 2 0.0029
53 SKIN HYPOPIGMENTATION 5 0.0028
54 ALLERGY TO ANIMAL 3 0.0028
55 CERVICAL RADICULOPATHY 2 0.0028
56 CONGENITAL HYDRONEPHROSIS 2 0.0028
57 APPLICATION SITE DISCOLOURATION 11 0.0027
58 ONYCHOMADESIS 11 0.0026
59 DISTRACTIBILITY 3 0.0026
60 LUMBAR RADICULOPATHY 3 0.0026
61 TINEA PEDIS 4 0.0025
62 INTERVERTEBRAL DISC SPACE NARROWING 2 0.0025
63 XEROSIS 3 0.0024
64 WHITE MATTER LESION 3 0.0024
65 HEPATIC INFECTION 3 0.0023
66 PRODUCT PHYSICAL CONSISTENCY ISSUE 13 0.0023
67 GLIOBLASTOMA 4 0.0023
68 CERVICAL SPINAL STENOSIS 4 0.0023
69 ABSCESS DRAINAGE 2 0.0023
70 ACROCHORDON 3 0.0023
71 ABSCESS ORAL 3 0.0022
72 IMMUNOGLOBULINS DECREASED 3 0.0022
73 CATAPLEXY 3 0.0021
74 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
75 MELANOCYTIC NAEVUS 9 0.0021
76 HYPOGONADISM 2 0.0020
77 BONE DEMINERALISATION 2 0.0019
78 LIPODYSTROPHY ACQUIRED 4 0.0019
79 BLOOD SODIUM ABNORMAL 2 0.0019
80 SHOULDER FRACTURE 3 0.0018
81 NAIL DISORDER 16 0.0018
82 CARBON DIOXIDE DECREASED 2 0.0017
83 CHEMICAL BURN 2 0.0017
84 CEREBRAL VENTRICLE DILATATION 2 0.0017
85 DYSLEXIA 2 0.0017
86 EYELID DISORDER 4 0.0017
87 APPLICATION SITE DISCHARGE 2 0.0017
88 ALLODYNIA 2 0.0017
89 PAPULE 12 0.0017
90 GROIN ABSCESS 2 0.0017
91 KYPHOSIS 3 0.0017
92 INGROWING NAIL 4 0.0017
93 DIVERTICULUM INTESTINAL 7 0.0016
94 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0016
95 GRIP STRENGTH DECREASED 14 0.0016
96 ECONOMIC PROBLEM 24 0.0016
97 DACRYOSTENOSIS ACQUIRED 2 0.0015
98 JOINT NOISE 3 0.0015
99 INFUSION SITE HAEMORRHAGE 5 0.0015
100 DERMATITIS PSORIASIFORM 3 0.0015
101 ANHEDONIA 38 0.0014
102 APPLICATION SITE INFLAMMATION 2 0.0014
103 MACULE 4 0.0014
104 AUDITORY DISORDER 2 0.0014
105 CONNECTIVE TISSUE DISORDER 2 0.0014
106 SKIN WEEPING 5 0.0014
107 COCCYDYNIA 2 0.0014
108 FREEZING PHENOMENON 5 0.0013
109 CHRONIC SINUSITIS 5 0.0013
110 EPICONDYLITIS 2 0.0013
111 REBOUND ACID HYPERSECRETION 4 0.0013
112 ONYCHOCLASIS 9 0.0013
113 END STAGE RENAL DISEASE 23 0.0013
114 SLOW SPEECH 3 0.0012
115 POLYP 8 0.0012
116 RETINAL TEAR 3 0.0012
117 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
118 BLOOD CALCIUM ABNORMAL 2 0.0012
119 SKIN PLAQUE 10 0.0012
120 EXPOSURE TO SARS-COV-2 2 0.0012
121 BLOOD CHLORIDE INCREASED 2 0.0012
122 ACTINIC KERATOSIS 3 0.0012
123 SKIN SWELLING 10 0.0012
124 PRODUCT PACKAGING DIFFICULT TO OPEN 3 0.0011
125 CHRONIC KIDNEY DISEASE 87 0.0011
126 FANCONI SYNDROME ACQUIRED 2 0.0011
127 SINUS BRADYCARDIA 11 0.0011
128 BLOOD POTASSIUM ABNORMAL 3 0.0011
129 APPLICATION SITE DISCOMFORT 2 0.0011
130 IMPAIRED QUALITY OF LIFE 16 0.0011
131 SKIN DISCOMFORT 3 0.0011
132 GAMBLING DISORDER 3 0.0011
133 APPLICATION SITE HAEMORRHAGE 3 0.0011
134 NEURODERMATITIS 4 0.0011
135 ELECTRIC SHOCK SENSATION 3 0.0011
136 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 18 0.0011
137 MYELOPATHY 2 0.0011
138 MENOMETRORRHAGIA 2 0.0010
139 NECK INJURY 3 0.0010
140 HYPOGEUSIA 2 0.0010
141 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
142 PROSTATOMEGALY 4 0.0010
143 URINE ANALYSIS ABNORMAL 3 0.0010
144 LARGE INTESTINAL STENOSIS 2 0.0010
145 MYELOFIBROSIS 3 0.0010
146 FUNGAL SKIN INFECTION 4 0.0010
147 EYE INJURY 3 0.0010
148 EYELID PAIN 2 0.0010
149 MASTICATION DISORDER 3 0.0010
150 TRIGGER FINGER 4 0.0010
151 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
152 HYPERPARATHYROIDISM 2 0.0010
153 ABDOMINAL ADHESIONS 3 0.0009
154 DEVICE CONNECTION ISSUE 2 0.0009
155 ANAL ABSCESS 5 0.0009
156 HORDEOLUM 4 0.0009
157 VITAMIN D DEFICIENCY 9 0.0009
158 OSTEOPENIA 14 0.0009
159 ENDOMETRIAL CANCER 2 0.0009
160 ACCIDENT AT WORK 2 0.0009
161 CYTOKINE RELEASE SYNDROME 18 0.0009
162 PLANTAR FASCIITIS 3 0.0009
163 BREAST MASS 6 0.0009
164 HEPATIC CYST 3 0.0009
165 BLOOD LOSS ANAEMIA 2 0.0009
166 CERVICAL VERTEBRAL FRACTURE 3 0.0009
167 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
168 DEVICE DISLOCATION 37 0.0009
169 SQUAMOUS CELL CARCINOMA 8 0.0008
170 PRODUCT SUPPLY ISSUE 6 0.0008
171 DERMATITIS ATOPIC 44 0.0008
172 BRONCHITIS CHRONIC 2 0.0008
173 MENISCUS INJURY 5 0.0008
174 CARTILAGE INJURY 2 0.0008
175 FOOT OPERATION 4 0.0008
176 DEVICE INFUSION ISSUE 2 0.0008
177 SPINAL OSTEOARTHRITIS 7 0.0008
178 SWELLING OF EYELID 5 0.0008
179 SNORING 3 0.0008
180 FACE INJURY 3 0.0008
181 TOXIC ENCEPHALOPATHY 4 0.0008
182 DERMATOMYOSITIS 2 0.0008
183 DERMATITIS CONTACT 9 0.0008
184 SCAB 9 0.0008
185 MEAN CELL VOLUME INCREASED 2 0.0008
186 DRUG TITRATION ERROR 2 0.0008
187 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
188 CATHETER SITE PAIN 2 0.0008
189 EPIGASTRIC DISCOMFORT 3 0.0008
190 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
191 SKIN ODOUR ABNORMAL 3 0.0008
192 LUNG OPACITY 2 0.0008
193 FUNGAL INFECTION 25 0.0007
194 ANAL FISSURE 4 0.0007
195 VITAMIN B12 DEFICIENCY 3 0.0007
196 ERYTHEMA OF EYELID 4 0.0007
197 PERIPHERAL VENOUS DISEASE 3 0.0007
198 DEMYELINATION 3 0.0007
199 APPLICATION SITE PAIN 16 0.0007
200 HAIR COLOUR CHANGES 9 0.0007
201 CHOLECYSTITIS INFECTIVE 2 0.0007
202 STREPTOCOCCAL INFECTION 4 0.0007
203 FORMICATION 5 0.0007
204 CHOLECYSTITIS ACUTE 4 0.0007
205 ABSCESS LIMB 3 0.0007
206 PRODUCT CONTAINER ISSUE 6 0.0007
207 HYPERTONIC BLADDER 2 0.0007
208 EYELID MARGIN CRUSTING 2 0.0007
209 HEPATIC CIRRHOSIS 13 0.0007
210 TONGUE DISORDER 5 0.0007
211 LUMBAR SPINAL STENOSIS 2 0.0007
212 OSTEOARTHRITIS 29 0.0007
213 UTERINE LEIOMYOMA 5 0.0007
214 PHYSICAL DISABILITY 3 0.0007
215 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
216 HEPATOTOXICITY 15 0.0007
217 INFUSION SITE REACTION 2 0.0007
218 ATYPICAL PNEUMONIA 2 0.0007
219 CENTRAL VENOUS CATHETERISATION 2 0.0007
220 IMPAIRED GASTRIC EMPTYING 9 0.0007
221 ADRENAL INSUFFICIENCY 8 0.0007
222 PATHOGEN RESISTANCE 6 0.0007
223 DERMATITIS ACNEIFORM 4 0.0007
224 SYNOVIAL CYST 3 0.0006
225 DECREASED ACTIVITY 7 0.0006
226 APHTHOUS ULCER 5 0.0006
227 ROSACEA 3 0.0006
228 NEPHROPATHY 6 0.0006
229 PRE-EXISTING CONDITION IMPROVED 4 0.0006
230 INFUSION SITE SWELLING 4 0.0006
231 BLEPHAROSPASM 4 0.0006
232 SKIN ABRASION 3 0.0006
233 INFUSION SITE PRURITUS 2 0.0006
234 BREAST CANCER RECURRENT 2 0.0006
235 FOOT FRACTURE 12 0.0006
236 LOCALISED INFECTION 15 0.0006
237 APPLICATION SITE VESICLES 4 0.0006
238 SKIN FISSURES 12 0.0006
239 NASAL POLYPS 3 0.0006
240 DEAFNESS NEUROSENSORY 2 0.0006
241 SKIN HAEMORRHAGE 9 0.0006
242 HAIR DISORDER 5 0.0006
243 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
244 LYME DISEASE 2 0.0006
245 DEVICE MALFUNCTION 42 0.0006
246 QUALITY OF LIFE DECREASED 8 0.0006
247 CORONARY ARTERIAL STENT INSERTION 3 0.0006
248 DYSLIPIDAEMIA 3 0.0006
249 TEMPERATURE INTOLERANCE 6 0.0006
250 MUSCLE STRAIN 5 0.0006
251 LARGE INTESTINE POLYP 4 0.0006
252 BURSITIS 7 0.0006
253 BONE DENSITY DECREASED 18 0.0006
254 DERMATITIS 12 0.0006
255 CARPAL TUNNEL SYNDROME 8 0.0006
256 SCRATCH 6 0.0006
257 PSORIATIC ARTHROPATHY 23 0.0006
258 SEASONAL ALLERGY 8 0.0006
259 DIVERTICULUM 4 0.0006
260 ANAL FISTULA 3 0.0006
261 APPENDICECTOMY 2 0.0006
262 ISCHAEMIC STROKE 10 0.0006
263 OVERWEIGHT 3 0.0006
264 GOUT 10 0.0006
265 PAIN OF SKIN 15 0.0006
266 ECZEMA 29 0.0006
267 MONOCYTE COUNT INCREASED 2 0.0006
268 FAECES SOFT 4 0.0005
269 OESOPHAGITIS 6 0.0005
270 ASTHMATIC CRISIS 2 0.0005
271 SKIN LESION 15 0.0005
272 INTESTINAL ISCHAEMIA 3 0.0005
273 PROSTATIC DISORDER 3 0.0005
274 HYPERKERATOSIS 3 0.0005
275 ARTHROPOD BITE 4 0.0005
276 SUNBURN 4 0.0005
277 PRODUCT LEAKAGE 3 0.0005
278 PERIORBITAL SWELLING 3 0.0005
279 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
280 SLEEP APNOEA SYNDROME 10 0.0005
281 CLAVICLE FRACTURE 2 0.0005
282 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
283 EXERCISE TOLERANCE DECREASED 3 0.0005
284 CONCUSSION 4 0.0005
285 POST PROCEDURAL HAEMORRHAGE 6 0.0005
286 FAECES HARD 2 0.0005
287 MUSCLE RUPTURE 2 0.0005
288 PSORIASIS 67 0.0005
289 SPLENOMEGALY 6 0.0005
290 SEXUAL DYSFUNCTION 6 0.0005
291 DECREASED INTEREST 3 0.0005
292 INCORRECT PRODUCT ADMINISTRATION DURATION 11 0.0005
293 DRUG RESISTANCE 13 0.0005
294 LIGAMENT SPRAIN 5 0.0005
295 POLLAKIURIA 21 0.0005
296 HYPERLIPIDAEMIA 6 0.0005
297 LOW TURNOVER OSTEOPATHY 2 0.0005
298 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
299 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
300 RHINITIS 4 0.0005
301 INGUINAL HERNIA 3 0.0005
302 RENAL FAILURE 65 0.0005
303 INITIAL INSOMNIA 5 0.0005
304 LEG AMPUTATION 2 0.0005
305 AGRANULOCYTOSIS 9 0.0005
306 POOR VENOUS ACCESS 5 0.0005
307 MUSCLE INJURY 4 0.0005
308 APPLICATION SITE IRRITATION 6 0.0005
309 EMBOLISM 4 0.0005
310 EYE DISCHARGE 5 0.0005
311 MULTIPLE INJURIES 3 0.0005
312 HALLUCINATIONS, MIXED 2 0.0005
313 FOREIGN BODY SENSATION IN EYES 3 0.0005
314 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
315 MOVEMENT DISORDER 15 0.0005
316 BONE LOSS 7 0.0005
317 ABNORMAL SENSATION IN EYE 2 0.0005
318 HIATUS HERNIA 6 0.0005
319 HEPATIC LESION 2 0.0005
320 HAEMORRHOIDS 9 0.0005
321 EYE PAIN 26 0.0005
322 BIPOLAR DISORDER 5 0.0005
323 NODULE 6 0.0005
324 APPLICATION SITE ERYTHEMA 12 0.0005
325 INSURANCE ISSUE 7 0.0005
326 DYSPHEMIA 2 0.0005
327 INTENTIONAL DOSE OMISSION 13 0.0005
328 EMOTIONAL DISTRESS 55 0.0005
329 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
330 LIMB INJURY 12 0.0004
331 OBESITY 7 0.0004
332 SKIN EXFOLIATION 37 0.0004
333 HAEMOGLOBIN INCREASED 2 0.0004
334 RIB FRACTURE 9 0.0004
335 NEPHROLITHIASIS 20 0.0004
336 DROOLING 3 0.0004
337 HAIR GROWTH ABNORMAL 3 0.0004
338 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
339 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
340 DEFAECATION URGENCY 3 0.0004
341 ARTERIOSCLEROSIS 4 0.0004
342 PHOTOSENSITIVITY REACTION 7 0.0004
343 RESPIRATORY TRACT INFECTION 11 0.0004
344 COLITIS MICROSCOPIC 2 0.0004
345 PARALYSIS 6 0.0004
346 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
347 HYPERSOMNIA 12 0.0004
348 POOR QUALITY SLEEP 9 0.0004
349 LIMB OPERATION 2 0.0004
350 GASTROINTESTINAL TOXICITY 2 0.0004
351 HUMERUS FRACTURE 2 0.0004
352 RASH PUSTULAR 3 0.0004
353 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
354 ORAL DISORDER 3 0.0004
355 INCORRECT DOSAGE ADMINISTERED 2 0.0004
356 RENAL TUBULAR NECROSIS 4 0.0004
357 MUSCLE SPASTICITY 5 0.0004
358 MUSCULOSKELETAL DISCOMFORT 7 0.0004
359 RASH PRURITIC 22 0.0004
360 ACUTE KIDNEY INJURY 62 0.0004
361 SINUS DISORDER 8 0.0004
362 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
363 PULMONARY MASS 6 0.0004
364 RASH PAPULAR 9 0.0004
365 APPLICATION SITE SWELLING 2 0.0004
366 ERYSIPELAS 2 0.0004
367 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
368 TASTE DISORDER 8 0.0004
369 EYELID PTOSIS 4 0.0004
370 SKIN DISCOLOURATION 18 0.0004
371 ROTATOR CUFF SYNDROME 5 0.0004
372 OSTEOPOROSIS 16 0.0004
373 ATRIOVENTRICULAR BLOCK 3 0.0004
374 ANKLE FRACTURE 6 0.0004
375 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
376 TOOTH LOSS 8 0.0004
377 WEIGHT FLUCTUATION 4 0.0004
378 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
379 TOOTH INFECTION 5 0.0004
380 RENAL CYST 3 0.0004
381 DISCOMFORT 23 0.0004
382 HAIR TEXTURE ABNORMAL 5 0.0004
383 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
384 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
385 COMPRESSION FRACTURE 2 0.0004
386 SENSORY LOSS 3 0.0004
387 GINGIVITIS 2 0.0004
388 NEURALGIA 9 0.0004
389 SINUS CONGESTION 5 0.0004
390 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
391 SKIN LACERATION 4 0.0004
392 MUSCULOSKELETAL DISORDER 7 0.0004
393 HYDROCEPHALUS 2 0.0004
394 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
395 ASPIRATION 4 0.0004
396 JAW DISORDER 2 0.0004
397 POST PROCEDURAL COMPLICATION 7 0.0004
398 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
399 INTRACRANIAL PRESSURE INCREASED 2 0.0004
400 ORAL HERPES 7 0.0004
401 APHONIA 5 0.0004
402 OCULAR HYPERAEMIA 17 0.0004
403 MALNUTRITION 4 0.0004
404 ACUTE PULMONARY OEDEMA 2 0.0004
405 OCULAR DISCOMFORT 4 0.0004
406 SENSATION OF FOREIGN BODY 3 0.0004
407 INFUSION SITE ERYTHEMA 3 0.0004
408 SLEEP DISORDER 25 0.0004
409 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
410 APPLICATION SITE PRURITUS 8 0.0004
411 DRY SKIN 47 0.0004
412 VITAMIN D DECREASED 3 0.0004
413 HAEMATURIA 12 0.0004
414 ERYTHEMA 72 0.0003
415 NEOPLASM 4 0.0003
416 EYE IRRITATION 20 0.0003
417 HERPES VIRUS INFECTION 2 0.0003
418 MOUTH SWELLING 2 0.0003
419 BLOOD URIC ACID INCREASED 2 0.0003
420 DYSPNOEA EXERTIONAL 13 0.0003
421 DIABETES MELLITUS 26 0.0003
422 HYPERCHLORHYDRIA 2 0.0003
423 LUNG INFILTRATION 3 0.0003
424 ENERGY INCREASED 2 0.0003
425 BLOOD IRON DECREASED 4 0.0003
426 CATARACT OPERATION 2 0.0003
427 ATAXIA 4 0.0003
428 FACIAL PAIN 3 0.0003
429 PRODUCT PRESCRIBING ERROR 8 0.0003
430 THIRST 6 0.0003
431 CHOLECYSTITIS 4 0.0003
432 COLON CANCER 5 0.0003
433 WRIST FRACTURE 4 0.0003
434 GASTROENTERITIS VIRAL 6 0.0003
435 LUPUS-LIKE SYNDROME 3 0.0003
436 RESTLESS LEGS SYNDROME 6 0.0003
437 SKIN DISORDER 11 0.0003
438 EYE PRURITUS 11 0.0003
439 INCREASED TENDENCY TO BRUISE 3 0.0003
440 PRODUCT DISTRIBUTION ISSUE 3 0.0003
441 TENDONITIS 5 0.0003
442 URINARY TRACT INFECTION 55 0.0003
443 FLANK PAIN 3 0.0003
444 DERMATITIS ALLERGIC 4 0.0003
445 PRURITUS 122 0.0003
446 PROTEINURIA 6 0.0003
447 RESPIRATORY TRACT CONGESTION 5 0.0003
448 EYE INFLAMMATION 3 0.0003
449 PRODUCTIVE COUGH 15 0.0003
450 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
451 ENTERITIS 2 0.0003
452 SINUSITIS 32 0.0003
453 ACUTE RESPIRATORY FAILURE 6 0.0003
454 ATELECTASIS 3 0.0003
455 HERNIA 6 0.0003
456 CARDIAC FLUTTER 2 0.0003
457 BACK DISORDER 5 0.0003
458 MULTIPLE FRACTURES 5 0.0003
459 DEPRESSION 69 0.0003
460 RENAL INJURY 9 0.0003
461 EAR INFECTION 8 0.0003
462 LACRIMATION INCREASED 9 0.0003
463 TOXIC SKIN ERUPTION 3 0.0003
464 CELLULITIS 15 0.0003
465 PERICARDITIS 5 0.0003
466 COLITIS ISCHAEMIC 2 0.0003
467 TOOTH ABSCESS 3 0.0003
468 PRODUCT USE IN UNAPPROVED INDICATION 73 0.0003
469 NEUTROPHIL COUNT INCREASED 3 0.0003
470 SCAR 5 0.0003
471 LIMB DISCOMFORT 9 0.0003
472 THERAPY NON-RESPONDER 13 0.0003
473 DIVERTICULITIS 8 0.0003
474 ATRIAL FIBRILLATION 28 0.0003
475 ORTHOSTATIC HYPOTENSION 5 0.0003
476 MASS 4 0.0003
477 HEAD INJURY 9 0.0003
478 SKIN REACTION 4 0.0003
479 FALL 94 0.0003
480 EATING DISORDER 6 0.0003
481 RETCHING 6 0.0003
482 BREAST PAIN 3 0.0003
483 OROPHARYNGEAL PAIN 26 0.0003
484 BODY HEIGHT DECREASED 3 0.0003
485 PRODUCT QUALITY ISSUE 38 0.0003
486 PRODUCT DOSE OMISSION ISSUE 82 0.0003
487 HOT FLUSH 21 0.0003
488 RHINORRHOEA 18 0.0003
489 FAECES DISCOLOURED 6 0.0003
490 LEUKOCYTOSIS 5 0.0003
491 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
492 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
493 PRODUCT PRESCRIBING ISSUE 6 0.0003
494 PULMONARY THROMBOSIS 3 0.0003
495 ALOPECIA 54 0.0003
496 PAIN IN EXTREMITY 81 0.0003
497 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
498 SURGERY 16 0.0003
499 MOUTH HAEMORRHAGE 2 0.0003
500 EXPIRED PRODUCT ADMINISTERED 9 0.0003
501 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
502 HYPOPHOSPHATAEMIA 2 0.0003
503 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
504 TOOTH DISORDER 6 0.0003
505 NERVE INJURY 3 0.0003
506 CONJUNCTIVITIS 5 0.0003
507 HEPATIC STEATOSIS 5 0.0003
508 ORAL PAIN 6 0.0003
509 DEAFNESS 7 0.0003
510 EPISTAXIS 20 0.0003
511 ARTHRITIS 21 0.0003
512 JOINT STIFFNESS 7 0.0003
513 THERAPY INTERRUPTED 19 0.0003
514 EYE INFECTION 3 0.0003
515 REBOUND EFFECT 3 0.0003
516 RASH 115 0.0003
517 COLITIS 10 0.0003
518 ANXIETY 75 0.0003
519 PRODUCT AVAILABILITY ISSUE 6 0.0003
520 BLOOD URINE PRESENT 5 0.0003
521 AORTIC ANEURYSM 2 0.0003
522 FEELING JITTERY 5 0.0003
523 COVID-19 46 0.0003
524 HIP ARTHROPLASTY 4 0.0003
525 BOWEL MOVEMENT IRREGULARITY 2 0.0003
526 LOWER LIMB FRACTURE 5 0.0003
527 DRUG INEFFECTIVE 342 0.0003
528 MUSCULOSKELETAL CHEST PAIN 4 0.0003
529 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
530 DELUSION 4 0.0003
531 PNEUMONITIS 7 0.0003
532 THERAPY PARTIAL RESPONDER 4 0.0003
533 BASAL CELL CARCINOMA 4 0.0003
534 RECTAL HAEMORRHAGE 11 0.0003
535 AFFECTIVE DISORDER 2 0.0003
536 TREATMENT FAILURE 21 0.0003
537 THERAPY CESSATION 13 0.0003
538 FURUNCLE 2 0.0003
539 NEUROPATHY PERIPHERAL 24 0.0003
540 CATARACT 15 0.0003
541 ARTHROPATHY 14 0.0003
542 HALLUCINATION, AUDITORY 4 0.0003
543 RASH ERYTHEMATOUS 12 0.0003
544 SCIATICA 4 0.0003
545 PAIN 154 0.0003
546 ACNE 19 0.0003
547 HYPOTHYROIDISM 8 0.0003
548 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
549 HIP FRACTURE 8 0.0002
550 HEPATITIS C 3 0.0002
551 PRODUCT ADMINISTRATION ERROR 5 0.0002
552 NOCTURIA 3 0.0002
553 FIBROMYALGIA 6 0.0002
554 DRY MOUTH 20 0.0002
555 RESTLESSNESS 9 0.0002
556 PRODUCT DOSE OMISSION 16 0.0002
557 ENCEPHALOPATHY 6 0.0002
558 CHEST DISCOMFORT 25 0.0002
559 HICCUPS 2 0.0002
560 SPINAL OPERATION 3 0.0002
561 BALANCE DISORDER 21 0.0002
562 ILLNESS 25 0.0002
563 EYE SWELLING 9 0.0002
564 CYST 3 0.0002
565 ILEUS 3 0.0002
566 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
567 DRY EYE 12 0.0002
568 SKIN IRRITATION 11 0.0002
569 DYSSTASIA 7 0.0002
570 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
571 INTESTINAL OBSTRUCTION 9 0.0002
572 UNEVALUABLE EVENT 18 0.0002
573 TYPE 2 DIABETES MELLITUS 8 0.0002
574 KNEE ARTHROPLASTY 5 0.0002
575 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
576 CONDITION AGGRAVATED 72 0.0002
577 FACIAL PARALYSIS 2 0.0002
578 JOINT INJURY 5 0.0002
579 RESPIRATORY DISORDER 7 0.0002
580 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42 0.0002
581 NECK PAIN 13 0.0002
582 PARANOIA 4 0.0002
583 THERAPEUTIC RESPONSE DECREASED 14 0.0002
584 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
585 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
586 BLOOD CALCIUM INCREASED 2 0.0002
587 GASTRITIS 6 0.0002
588 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 46 0.0002
589 IMMUNOSUPPRESSION 2 0.0002
590 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
591 HEAD DISCOMFORT 4 0.0002
592 CONSTIPATION 49 0.0002
593 BACK PAIN 52 0.0002
594 ARTHRALGIA 93 0.0002
595 MUSCLE SPASMS 41 0.0002
596 HEAVY MENSTRUAL BLEEDING 2 0.0002
597 HEART RATE IRREGULAR 5 0.0002
598 DYSPHAGIA 21 0.0002
599 TOOTHACHE 4 0.0002
600 ABDOMINAL DISTENSION 23 0.0002
601 C-REACTIVE PROTEIN INCREASED 8 0.0002
602 PERIPHERAL COLDNESS 3 0.0002
603 NIGHT SWEATS 7 0.0002
604 BLOOD GLUCOSE ABNORMAL 4 0.0002
605 PROCEDURAL PAIN 6 0.0002
606 BRONCHITIS 16 0.0002
607 ORAL DISCOMFORT 3 0.0002
608 HYPOMAGNESAEMIA 3 0.0002
609 HEPATIC ENCEPHALOPATHY 2 0.0002
610 RENAL IMPAIRMENT 18 0.0002
611 PERIPHERAL SWELLING 33 0.0002
612 HYPOAESTHESIA 32 0.0002
613 DIARRHOEA 138 0.0002
614 BLOOD TEST ABNORMAL 3 0.0002
615 VERTIGO 13 0.0002
616 HALLUCINATION 16 0.0002
617 SINUS TACHYCARDIA 3 0.0002
618 FATIGUE 163 0.0002
619 INCREASED APPETITE 4 0.0002
620 PARAESTHESIA ORAL 3 0.0002
621 COUGH 58 0.0002
622 DECREASED APPETITE 48 0.0002
623 NASAL CONGESTION 12 0.0002
624 HEPATOMEGALY 2 0.0002
625 INJECTION SITE REACTION 14 0.0002
626 URINARY INCONTINENCE 6 0.0002
627 DISABILITY 4 0.0002
628 INABILITY TO AFFORD MEDICATION 2 0.0002
629 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
630 IMMUNODEFICIENCY 3 0.0002
631 HAEMORRHAGE INTRACRANIAL 3 0.0002
632 WEIGHT DECREASED 56 0.0002
633 AGEUSIA 5 0.0002
634 RASH MACULAR 7 0.0002
635 DEEP VEIN THROMBOSIS 13 0.0002
636 BLOOD POTASSIUM DECREASED 6 0.0002
637 SEIZURE 23 0.0002
638 EMPHYSEMA 2 0.0002
639 BLOOD COUNT ABNORMAL 3 0.0002
640 CONTUSION 19 0.0002
641 DRY THROAT 2 0.0002
642 DRUG LEVEL DECREASED 2 0.0002
643 EPILEPSY 6 0.0002
644 MOTOR DYSFUNCTION 2 0.0002
645 BLOOD PRESSURE DECREASED 13 0.0002
646 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
647 SKIN BURNING SENSATION 14 0.0002
648 THYROID DISORDER 3 0.0002
649 HEADACHE 122 0.0002
650 INFLAMMATION 10 0.0002
651 MUSCULAR WEAKNESS 22 0.0002
652 LUNG INFECTION 3 0.0002
653 RASH GENERALISED 5 0.0002
654 SWOLLEN TONGUE 6 0.0002
655 WEIGHT INCREASED 43 0.0002
656 NEUTROPENIA 26 0.0002
657 FOLLICULITIS 2 0.0002
658 INJECTION SITE DISCOMFORT 2 0.0002
659 BLOOD PRESSURE INCREASED 29 0.0002
660 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
661 PULMONARY EMBOLISM 18 0.0002
662 JOINT DISLOCATION 2 0.0002
663 PNEUMOTHORAX 3 0.0002
664 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
665 HYPERSENSITIVITY 35 0.0002
666 CYSTITIS 6 0.0002
667 PYREXIA 65 0.0002
668 INSOMNIA 50 0.0002
669 DYSPNOEA 106 0.0002
670 IMPAIRED WORK ABILITY 4 0.0002
671 PRODUCT USE ISSUE 35 0.0002
672 FEAR 5 0.0002
673 ASTHMA 21 0.0002
674 SKIN CANCER 4 0.0002
675 BLOOD POTASSIUM INCREASED 3 0.0002
676 NASOPHARYNGITIS 34 0.0002
677 OEDEMA 10 0.0002
678 BACK INJURY 2 0.0002
679 EYE DISORDER 6 0.0002
680 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
681 VISION BLURRED 25 0.0002
682 STAPHYLOCOCCAL INFECTION 6 0.0002
683 DENTAL CARIES 2 0.0002
684 DIZZINESS 90 0.0002
685 VIRAL INFECTION 6 0.0002
686 TACHYCARDIA 16 0.0002
687 FEELING HOT 11 0.0002
688 SEPSIS 20 0.0002
689 PNEUMONIA 58 0.0002
690 DEMENTIA 5 0.0002
691 PARAESTHESIA 28 0.0002
692 BLOOD CALCIUM DECREASED 2 0.0002
693 CANDIDA INFECTION 3 0.0002
694 DISORIENTATION 7 0.0002
695 MICTURITION URGENCY 2 0.0002
696 CHOLECYSTECTOMY 2 0.0002
697 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
698 RED BLOOD CELL COUNT DECREASED 5 0.0002
699 TINNITUS 8 0.0002
700 THROMBOSIS 14 0.0002
701 MUSCLE TWITCHING 4 0.0002
702 MADAROSIS 2 0.0002
703 SPEECH DISORDER 9 0.0002
704 BLOOD CHOLESTEROL INCREASED 8 0.0002
705 DEVICE USE ISSUE 3 0.0002
706 HYPERKALAEMIA 6 0.0002
707 INFLUENZA 19 0.0002
708 COLD SWEAT 3 0.0002
709 ASTHENIA 64 0.0002
710 LYMPHOCYTE COUNT DECREASED 3 0.0002
711 LABORATORY TEST ABNORMAL 5 0.0002
712 AMNESIA 11 0.0002
713 GALLBLADDER DISORDER 3 0.0002
714 MEMORY IMPAIRMENT 23 0.0002
715 CHEST PAIN 31 0.0002
716 ROAD TRAFFIC ACCIDENT 7 0.0002
717 MUSCLE RIGIDITY 2 0.0002
718 ABDOMINAL DISCOMFORT 28 0.0002
719 INFECTION 24 0.0002
720 PELVIC PAIN 3 0.0002
721 BONE DISORDER 3 0.0002
722 OEDEMA PERIPHERAL 20 0.0002
723 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
724 PALPITATIONS 19 0.0002
725 HEART RATE INCREASED 16 0.0002
726 VISUAL IMPAIRMENT 20 0.0002
727 HEPATIC ENZYME INCREASED 11 0.0002
728 BACTERIAL INFECTION 3 0.0002
729 MIDDLE INSOMNIA 3 0.0002
730 OXYGEN SATURATION DECREASED 9 0.0002
731 PNEUMONIA ASPIRATION 4 0.0002
732 SOMNOLENCE 32 0.0002
733 FLATULENCE 9 0.0002
734 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
735 FRACTURE 3 0.0002
736 GASTRIC ULCER 3 0.0002
737 INJECTION SITE IRRITATION 2 0.0002
738 BURNING SENSATION 11 0.0002
739 GAIT DISTURBANCE 30 0.0002
740 INTRAOCULAR PRESSURE INCREASED 2 0.0002
741 HYPOPHAGIA 4 0.0002
742 PULMONARY FIBROSIS 3 0.0002
743 HEPATITIS 4 0.0002
744 GASTROINTESTINAL DISORDER 14 0.0002
745 DRUG PRESCRIBING ERROR 3 0.0002
746 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
747 GLAUCOMA 3 0.0002
748 DRUG INTOLERANCE 15 0.0002
749 ANOREXIA 2 0.0002
750 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
751 PRESCRIBED OVERDOSE 3 0.0002
752 SKIN ULCER 4 0.0002
753 DIPLOPIA 4 0.0002
754 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
755 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
756 CHOKING 3 0.0002
757 MUSCULOSKELETAL PAIN 8 0.0002
758 BEDRIDDEN 2 0.0002
759 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
760 HAEMATOCRIT DECREASED 3 0.0002
761 HYPERTENSION 32 0.0002
762 BLOOD PRESSURE ABNORMAL 3 0.0002
763 UPPER LIMB FRACTURE 3 0.0002
764 SPINAL FRACTURE 3 0.0001
765 MALIGNANT MELANOMA 2 0.0001
766 FULL BLOOD COUNT DECREASED 3 0.0001
767 CONFUSIONAL STATE 24 0.0001
768 MUSCULOSKELETAL STIFFNESS 13 0.0001
769 DISTURBANCE IN ATTENTION 8 0.0001
770 LOSS OF CONSCIOUSNESS 19 0.0001
771 BONE MARROW FAILURE 3 0.0001
772 DISEASE RECURRENCE 7 0.0001
773 BODY TEMPERATURE INCREASED 3 0.0001
774 GINGIVAL BLEEDING 2 0.0001
775 MULTIPLE SCLEROSIS 7 0.0001
776 GASTRIC DISORDER 5 0.0001
777 MENTAL STATUS CHANGES 4 0.0001
778 PULMONARY HYPERTENSION 3 0.0001
779 HAEMOPTYSIS 4 0.0001
780 WOUND 4 0.0001
781 LUNG DISORDER 7 0.0001
782 HEART RATE DECREASED 5 0.0001
783 DYSPEPSIA 14 0.0001
784 INJURY 10 0.0001
785 DEVICE OCCLUSION 2 0.0001
786 SUICIDAL IDEATION 13 0.0001
787 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
788 PRODUCT ADHESION ISSUE 5 0.0001
789 CARDIOGENIC SHOCK 2 0.0001
790 HYPOACUSIS 6 0.0001
791 MOBILITY DECREASED 10 0.0001
792 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
793 DRUG INTERACTION 22 0.0001
794 TREMOR 23 0.0001
795 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
796 MYELODYSPLASTIC SYNDROME 2 0.0001
797 HYPERTHYROIDISM 2 0.0001
798 MENTAL DISORDER 6 0.0001
799 BLOOD CREATININE INCREASED 9 0.0001
800 HYPOKINESIA 2 0.0001
801 FLUSHING 14 0.0001
802 NAUSEA 109 0.0001
803 RESPIRATORY FAILURE 10 0.0001
804 GASTROENTERITIS 2 0.0001
805 MIGRAINE 13 0.0001
806 ACUTE MYOCARDIAL INFARCTION 4 0.0001
807 MALAISE 59 0.0001
808 SNEEZING 3 0.0001
809 PANCREATITIS ACUTE 3 0.0001
810 DYSARTHRIA 5 0.0001
811 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
812 CORONARY ARTERY DISEASE 4 0.0001
813 STOMATITIS 8 0.0001
814 PLEURAL EFFUSION 8 0.0001
815 DEVICE FAILURE 2 0.0001
816 ABDOMINAL PAIN UPPER 27 0.0001
817 ANAEMIA 25 0.0001
818 HOSPITALISATION 20 0.0001
819 HYPOKALAEMIA 6 0.0001
820 HYPOTENSION 26 0.0001
821 FEMUR FRACTURE 4 0.0001
822 OFF LABEL USE 113 0.0001
823 COGNITIVE DISORDER 6 0.0001
824 NERVOUS SYSTEM DISORDER 4 0.0001
825 MENINGIOMA 2 0.0001
826 TREATMENT NONCOMPLIANCE 7 0.0001
827 BRAIN FOG 2 0.0001
828 CYANOSIS 2 0.0001
829 HAEMATOCHEZIA 7 0.0001
830 ANAPHYLACTIC REACTION 7 0.0001
831 INJECTION SITE BRUISING 10 0.0001
832 BLOOD PRESSURE FLUCTUATION 3 0.0001
833 JOINT SWELLING 15 0.0001
834 HYPERHIDROSIS 16 0.0001
835 DYSKINESIA 5 0.0001
836 BLINDNESS 5 0.0001
837 CHOLELITHIASIS 4 0.0001
838 LETHARGY 7 0.0001
839 MANIA 2 0.0001
840 INJECTION SITE PAIN 37 0.0001
841 COAGULOPATHY 2 0.0001
842 LEUKOPENIA 6 0.0001
843 DEHYDRATION 16 0.0001
844 GAIT INABILITY 4 0.0001
845 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
846 VOMITING 56 0.0001
847 HAEMATEMESIS 3 0.0001
848 HEMIPARESIS 2 0.0001
849 MYALGIA 20 0.0001
850 CARDIAC DISORDER 11 0.0001
851 SWELLING 11 0.0001
852 HAEMOGLOBIN DECREASED 12 0.0001
853 ERECTILE DYSFUNCTION 3 0.0001
854 BLOOD GLUCOSE INCREASED 22 0.0001
855 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
856 HAEMATOMA 3 0.0001
857 EXPOSURE VIA SKIN CONTACT 3 0.0001
858 DEVICE DEFECTIVE 2 0.0001
859 SEPTIC SHOCK 5 0.0001
860 LOCAL SWELLING 2 0.0001
861 MUCOSAL INFLAMMATION 3 0.0001
862 RHEUMATOID ARTHRITIS 13 0.0001
863 INTENTIONAL PRODUCT MISUSE 10 0.0001
864 INCORRECT DOSE ADMINISTERED 26 0.0001
865 LYMPHADENOPATHY 4 0.0001
866 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
867 INJECTION SITE ERYTHEMA 14 0.0001
868 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
869 COLITIS ULCERATIVE 5 0.0001
870 CHILLS 13 0.0001
871 HYPERGLYCAEMIA 4 0.0001
872 PANIC ATTACK 4 0.0001
873 DYSGEUSIA 8 0.0001
874 ABDOMINAL PAIN 25 0.0001
875 BLISTER 6 0.0001
876 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
877 HYPONATRAEMIA 6 0.0001
878 TARDIVE DYSKINESIA 3 0.0001
879 BLOOD SODIUM DECREASED 2 0.0001
880 PAIN IN JAW 3 0.0001
881 HERPES ZOSTER 6 0.0001
882 INJECTION SITE SWELLING 8 0.0001
883 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
884 ERUCTATION 2 0.0001
885 NEEDLE ISSUE 3 0.0001
886 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
887 KIDNEY INFECTION 2 0.0001
888 PSYCHOTIC DISORDER 3 0.0001
889 SYNCOPE 10 0.0001
890 CARDIAC FAILURE 8 0.0001
891 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
892 THROMBOCYTOPENIA 11 0.0001
893 INJECTION SITE WARMTH 2 0.0001
894 RHABDOMYOLYSIS 4 0.0001
895 UNDERDOSE 7 0.0001
896 CARDIO-RESPIRATORY ARREST 4 0.0001
897 PANCREATITIS 5 0.0001
898 DEPRESSED MOOD 5 0.0001
899 METABOLIC ACIDOSIS 3 0.0001
900 IRRITABLE BOWEL SYNDROME 2 0.0001
901 LIVER FUNCTION TEST INCREASED 2 0.0001
902 DISEASE PROGRESSION 11 0.0001
903 LACTIC ACIDOSIS 3 0.0001
904 DEVICE LEAKAGE 4 0.0001
905 IMPAIRED HEALING 3 0.0001
906 OSTEONECROSIS 3 0.0001
907 PANCYTOPENIA 5 0.0001
908 GLOSSODYNIA 2 0.0001
909 THROAT IRRITATION 4 0.0001
910 NIGHTMARE 3 0.0001
911 BONE PAIN 5 0.0001
912 WHEEZING 5 0.0001
913 BLOOD GLUCOSE DECREASED 4 0.0001
914 DIABETIC KETOACIDOSIS 2 0.0001
915 CRYING 3 0.0001
916 DYSURIA 3 0.0001
917 INJECTION SITE MASS 3 0.0001
918 CARDIOVASCULAR DISORDER 2 0.0001
919 DRUG DOSE OMISSION 13 0.0001
920 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
921 ADVERSE DRUG REACTION 7 0.0001
922 SWELLING FACE 5 0.0001
923 NERVOUSNESS 4 0.0001
924 HAEMORRHAGE 8 0.0001
925 ADVERSE EVENT 7 0.0001
926 ABNORMAL BEHAVIOUR 3 0.0001
927 INFUSION RELATED REACTION 5 0.0001
928 FEELING ABNORMAL 18 0.0001
929 BREAST CANCER 7 0.0001
930 PLATELET COUNT DECREASED 8 0.0001
931 NEOPLASM MALIGNANT 5 0.0001
932 CARDIAC FAILURE CONGESTIVE 6 0.0001
933 INJECTION SITE PRURITUS 5 0.0001
934 JAUNDICE 2 0.0001
935 EXTRA DOSE ADMINISTERED 3 0.0001
936 ABNORMAL DREAMS 2 0.0001
937 FEELING COLD 2 0.0001
938 URTICARIA 12 0.0001
939 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
940 ANGINA PECTORIS 2 0.0001
941 PRODUCT SUBSTITUTION ISSUE 4 0.0001
942 LIVER FUNCTION TEST ABNORMAL 2 0.0001
943 DYSPHONIA 4 0.0001
944 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
945 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
946 AGITATION 5 0.0001
947 ASCITES 2 0.0001
948 ANGIOEDEMA 3 0.0001
949 LIVER DISORDER 3 0.0001
950 PULMONARY OEDEMA 3 0.0001
951 IRRITABILITY 4 0.0001
952 APHASIA 2 0.0001
953 EMOTIONAL DISORDER 2 0.0001
954 RENAL DISORDER 3 0.0001
955 DRUG-INDUCED LIVER INJURY 2 0.0001
956 COLORECTAL CANCER 3 0.0001
957 INJECTION SITE HAEMORRHAGE 5 0.0001
958 DEATH 53 0.0001
959 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
960 NO ADVERSE EVENT 11 0.0001
961 DEVICE DIFFICULT TO USE 4 0.0001
962 LIP SWELLING 2 0.0001
963 TOXICITY TO VARIOUS AGENTS 10 0.0001
964 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
965 CEREBROVASCULAR ACCIDENT 10 0.0001
966 FLUID RETENTION 3 0.0001
967 DEVICE USE ERROR 2 0.0001
968 HYPOXIA 2 0.0001
969 CEREBRAL HAEMORRHAGE 2 0.0001
970 DRUG EFFECT DECREASED 3 0.0001
971 ACCIDENTAL OVERDOSE 2 0.0001
972 BLADDER CANCER 3 0.0001
973 SUICIDE ATTEMPT 3 0.0000
974 LUNG NEOPLASM MALIGNANT 2 0.0000
975 DEVICE ISSUE 4 0.0000
976 ARRHYTHMIA 2 0.0000
977 COMA 2 0.0000
978 MYOCARDIAL INFARCTION 7 0.0000
979 AGGRESSION 2 0.0000
980 BRADYCARDIA 2 0.0000
981 INFLUENZA LIKE ILLNESS 3 0.0000
982 MEDICATION ERROR 2 0.0000
983 ILL-DEFINED DISORDER 2 0.0000
984 OVERDOSE 7 0.0000
985 DRUG DEPENDENCE 5 0.0000
986 FEBRILE NEUTROPENIA 2 0.0000
987 CARDIAC ARREST 2 0.0000
988 DRUG WITHDRAWAL SYNDROME 2 0.0000